Florence Dartiguenave

590 total citations
14 papers, 392 citations indexed

About

Florence Dartiguenave is a scholar working on Immunology, Surgery and Oncology. According to data from OpenAlex, Florence Dartiguenave has authored 14 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Surgery and 5 papers in Oncology. Recurrent topics in Florence Dartiguenave's work include Bladder and Urothelial Cancer Treatments (7 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (5 papers). Florence Dartiguenave is often cited by papers focused on Bladder and Urothelial Cancer Treatments (7 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (5 papers). Florence Dartiguenave collaborates with scholars based in Switzerland, France and Netherlands. Florence Dartiguenave's co-authors include Patrice Jichlinski, Laurent Derré, Denise Nardelli‐Haefliger, Valérie Cesson, Mathieu F. Chevalier, Perrine Bohner, Daniel E. Speiser, Ilaria Lucca, Sonia Domingos‐Pereira and Sara Trabanelli and has published in prestigious journals such as Journal of Clinical Investigation, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Florence Dartiguenave

13 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florence Dartiguenave Switzerland 8 280 169 146 70 28 14 392
Perrine Bohner Switzerland 4 204 0.7× 134 0.8× 90 0.6× 33 0.5× 18 0.6× 8 272
Jasper J. P. van Beek Netherlands 10 187 0.7× 67 0.4× 158 1.1× 70 1.0× 31 1.1× 10 332
Saïda Dadi United States 5 449 1.6× 140 0.8× 137 0.9× 92 1.3× 20 0.7× 6 534
Arabella Neva Italy 9 124 0.4× 55 0.3× 49 0.3× 107 1.5× 40 1.4× 11 364
Maya Eisenring Switzerland 7 205 0.7× 73 0.4× 97 0.7× 33 0.5× 33 1.2× 11 282
Betty Joe Canada 9 243 0.9× 72 0.4× 132 0.9× 55 0.8× 28 1.0× 22 364
Sharon Grisaru‐Tal Israel 6 197 0.7× 104 0.6× 115 0.8× 78 1.1× 84 3.0× 10 384
Saada Eid United States 10 119 0.4× 51 0.3× 106 0.7× 63 0.9× 68 2.4× 23 321
Yun Zhao Chen China 8 123 0.4× 57 0.3× 123 0.8× 86 1.2× 82 2.9× 8 306
Patrick Moebius Germany 9 173 0.6× 29 0.2× 166 1.1× 101 1.4× 62 2.2× 9 351

Countries citing papers authored by Florence Dartiguenave

Since Specialization
Citations

This map shows the geographic impact of Florence Dartiguenave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence Dartiguenave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence Dartiguenave more than expected).

Fields of papers citing papers by Florence Dartiguenave

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florence Dartiguenave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence Dartiguenave. The network helps show where Florence Dartiguenave may publish in the future.

Co-authorship network of co-authors of Florence Dartiguenave

This figure shows the co-authorship network connecting the top 25 collaborators of Florence Dartiguenave. A scholar is included among the top collaborators of Florence Dartiguenave based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florence Dartiguenave. Florence Dartiguenave is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Bräutigam, Konstantin, Florence Dartiguenave, Arnas Rakauskas, et al.. (2024). Urine biomarkers can predict prostate cancer and PI-RADS score prior to biopsy. Scientific Reports. 14(1). 18148–18148. 5 indexed citations
2.
Derré, Laurent, Ilaria Lucca, Valérie Cesson, et al.. (2023). Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potential. Journal for ImmunoTherapy of Cancer. 11(12). e008020–e008020. 3 indexed citations
3.
Lozano, Leyder Elena, Sébastien Lofek, Béatris Mastelic-Gavillet, et al.. (2023). Phenotype and Reactivity of Lymphocytes Expanded from Benign Prostate Hyperplasic Tissues and Prostate Cancer. Cancers. 15(12). 3114–3114. 1 indexed citations
4.
Chevalier, Mathieu F., Sulayman Benmerzoug, Valérie Cesson, et al.. (2022). Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments. Journal for ImmunoTherapy of Cancer. 10(8). e004880–e004880. 20 indexed citations
5.
Lucca, Ilaria, Laurent Derré, Valérie Cesson, et al.. (2022). Intravesical Ty21a Treatment of Non–muscle-invasive Bladder Cancer Shows a Good Safety Profile. European Urology Open Science. 45. 55–58. 5 indexed citations
6.
Mbaya, Olivier Tshiani, Massimo Valério, Florence Dartiguenave, et al.. (2022). ERAS® protocol improves survival after radical cystectomy: A single-center cohort study. Medicine. 101(35). e30258–e30258. 7 indexed citations
7.
Benmerzoug, Sulayman, Mathieu F. Chevalier, Valérie Cesson, et al.. (2021). Siglec-7 May Limit Natural Killer Cell–mediated Antitumor responses in Bladder Cancer Patients. European Urology Open Science. 34. 79–82. 9 indexed citations
8.
Benmerzoug, Sulayman, Mathieu F. Chevalier, Valérie Cesson, et al.. (2021). Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer Patients. European Urology Focus. 8(3). 748–751. 12 indexed citations
9.
Mastelic-Gavillet, Béatris, Leyder Elena Lozano, Tania Wyss, et al.. (2020). Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancer. European Journal of Cancer. 135. 173–182. 36 indexed citations
10.
Bohner, Perrine, Mathieu F. Chevalier, Valérie Cesson, et al.. (2019). Double Positive CD4+CD8+ T Cells Are Enriched in Urological Cancers and Favor T Helper-2 Polarization. Frontiers in Immunology. 10. 622–622. 62 indexed citations
11.
Derré, Laurent, Ilaria Lucca, Valérie Cesson, et al.. (2018). Intramuscular Immunization Induces Antigen-specific Antibodies in Urine. European Urology Focus. 6(2). 280–283.
12.
Chevalier, Mathieu F., Sara Trabanelli, Julien Racle, et al.. (2017). ILC2-modulated T cell–to-MDSC balance is associated with bladder cancer recurrence. Journal of Clinical Investigation. 127(8). 2916–2929. 172 indexed citations
13.
Derré, Laurent, Valérie Cesson, Ilaria Lucca, et al.. (2016). Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle–Invasive Bladder Cancer Patients. Clinical Cancer Research. 23(3). 717–725. 34 indexed citations
14.
Chevalier, Mathieu F., Perrine Bohner, Benoît Lhermitte, et al.. (2016). Immunoregulation of Dendritic Cell Subsets by Inhibitory Receptors in Urothelial Cancer. European Urology. 71(6). 854–857. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026